Showing 1 - 10 of 1,437
Background:Background: When guidelines for health economic evaluations prescribe that a societal perspective should be adopted, productivity costs should be included. However, previous research suggests that, in practice, productivity costs are often neglected. This may considerably bias the...
Persistent link: https://www.econbiz.de/10011005068
Persistent link: https://www.econbiz.de/10011005069
In past decades, studies focusing on new chemotherapeutic agents for patients with inoperable non-small-cell lung …+cisplatin was cost effective compared with gemcitabine+cisplatin in patients with non-squamous-cell carcinoma. In second …
Persistent link: https://www.econbiz.de/10011005070
. Because many of these patients experience chronic endobronchial colonization and have to take antibiotics and be treated as … inpatients, societal costs of CF may be high. As the disease severity varies considerably among patients, costs may differ … between patients. Abstract: Objectives:Objectives: Our objectives were to calculate the average total costs of CF per patient …
Persistent link: https://www.econbiz.de/10011005071
Background:Background: National EQ-5D value sets are developed because preferences for health may vary in different populations. UK values are lower than US values for most of the 243 possible EQ-5D health states. Although similar protocols were used for data collection, analytic choices...
Persistent link: https://www.econbiz.de/10011005072
economic impact of non-remission on health service use and costs over 12 months from the index episode in patients with … research database between 2001 and 2006. The records of 88 935 patients aged ≥18 years, diagnosed with depression and in … health service use and cost over the 12-month study period, by remission status, where remission is defined as patients not …
Persistent link: https://www.econbiz.de/10011005073
European countries, i.e. those with BMD T-score of -2.5 or less or prevalent vertebral fracture. Patients receiving denosumab …
Persistent link: https://www.econbiz.de/10011005074
Introduction: Little is known regarding healthcare costs for HIV/AIDS patients in the era of highly active … antiretroviral therapy (HAART) and subgroups of patients according to the severity and progression of HIV infection in Sweden. The … objective of this study is therefore to describe the direct medical resource use and cost of healthcare for HIV patients at a …
Persistent link: https://www.econbiz.de/10011005075
The design of decision-analytic models for cost-effectiveness analysis has been the subject of discussion. The current work addresses this issue by noting that, when time is to be explicitly modelled, we need to represent phenomena occurring in continuous time. Models evaluated in continuous...
Persistent link: https://www.econbiz.de/10011005076
Persistent link: https://www.econbiz.de/10011005077